Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Junker

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|September 10, 2011
Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agentsWaleed Ghanima, Peter Junker, Hans Carl Hasselbalch, et al.
Plos One|March 8, 2013
On the origin of rheumatoid arthritis: the impact of environment and genes--a population based twin studyAnders J Svendsen, Kirsten O Kyvik, Gunnar Houen, et al.
Plos One|June 11, 2014
Risk of lymphoma and solid cancer among patients with rheumatoid arthritis in a primary care settingChristen Lykkegaard Andersen, Hanne Lindegaard, Hanne Vestergaard, et al.
Frontiers in Immunology|March 29, 2021
Altered Antibody Response to Epstein-Barr Virus in Patients With Rheumatoid Arthritis and Healthy Subjects Predisposed to the Disease. A Twin StudyAnders J Svendsen, Marie Christine Wulff Westergaard, Anette Holck Draborg, et al.
Clinical and Experimental Rheumatology|May 11, 2018
Type IV collagen metabolism is associated with disease activity, radiographic progression and response to tocilizumab in rheumatoid arthritisNatasja Stæhr Gudmann, Peter Junker, Pernille Juhl, et al.
Cytokine|March 8, 2017
Expression of soluble CD83 in plasma from early-stage rheumatoid arthritis patients is not modified by anti-TNF-α therapyAnne-Mette Kristensen, Kristian Stengaard-Pedersen, Merete Lund Hetland, et al.
The Journal of Rheumatology|September 3, 2011
Patterns of magnetic resonance imaging bone erosion in rheumatoid arthritis--which bones are most frequently involved and show the most change?Mikkel Ostergaard, Uffe Møller Døhn, Anne Duer-Jensen, et al.
Clinical and Experimental Rheumatology|May 13, 2015
Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDsStinne Ravn Greisen, Holger Jon Møller, Kristian Stengaard-Pedersen, et al.
Clinical and Experimental Rheumatology|September 10, 2019
Increased serum levels of microfibrillar-associated protein 4 (MFAP4) are not associated with clinical synovitis in rheumatoid arthritis but may reflect underlying cardiovascular comorbiditySaida Farah Issa, Hanne M Lindegaard, Tove Lorenzen, et al.
Arthritis Research & Therapy|November 1, 2014
Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritisJulie K Laustsen, Tue K Rasmussen, Kristian Stengaard-Pedersen, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|September 10, 2011
Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agentsWaleed Ghanima, Peter Junker, Hans Carl Hasselbalch, et al.
Plos One|March 8, 2013
On the origin of rheumatoid arthritis: the impact of environment and genes--a population based twin studyAnders J Svendsen, Kirsten O Kyvik, Gunnar Houen, et al.
Plos One|June 11, 2014
Risk of lymphoma and solid cancer among patients with rheumatoid arthritis in a primary care settingChristen Lykkegaard Andersen, Hanne Lindegaard, Hanne Vestergaard, et al.
Frontiers in Immunology|March 29, 2021
Altered Antibody Response to Epstein-Barr Virus in Patients With Rheumatoid Arthritis and Healthy Subjects Predisposed to the Disease. A Twin StudyAnders J Svendsen, Marie Christine Wulff Westergaard, Anette Holck Draborg, et al.
Clinical and Experimental Rheumatology|May 11, 2018
Type IV collagen metabolism is associated with disease activity, radiographic progression and response to tocilizumab in rheumatoid arthritisNatasja Stæhr Gudmann, Peter Junker, Pernille Juhl, et al.
Cytokine|March 8, 2017
Expression of soluble CD83 in plasma from early-stage rheumatoid arthritis patients is not modified by anti-TNF-α therapyAnne-Mette Kristensen, Kristian Stengaard-Pedersen, Merete Lund Hetland, et al.
The Journal of Rheumatology|September 3, 2011
Patterns of magnetic resonance imaging bone erosion in rheumatoid arthritis--which bones are most frequently involved and show the most change?Mikkel Ostergaard, Uffe Møller Døhn, Anne Duer-Jensen, et al.
Clinical and Experimental Rheumatology|May 13, 2015
Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDsStinne Ravn Greisen, Holger Jon Møller, Kristian Stengaard-Pedersen, et al.
Clinical and Experimental Rheumatology|September 10, 2019
Increased serum levels of microfibrillar-associated protein 4 (MFAP4) are not associated with clinical synovitis in rheumatoid arthritis but may reflect underlying cardiovascular comorbiditySaida Farah Issa, Hanne M Lindegaard, Tove Lorenzen, et al.
Arthritis Research & Therapy|November 1, 2014
Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritisJulie K Laustsen, Tue K Rasmussen, Kristian Stengaard-Pedersen, et al.
Pageof 8